Menses inducer

Rageau, J. Les plantes medicinales de la Nouvelle Caledonie. Trav Doc de Lorstom No 23, Paris 1973. Hilton-Simpson, M. W. Arab medicine and surgery. Oxford Univ Press, Humphrey Milford, London, 1922. Jochle, W. Menses-inducing drugs their role in Antique, Medieval and Rennaissance gynecology and birth control. Contraception 1974 10 425-439. 

Maytenus ilicifolia from southern South America has been used as a menses inducer by indigenous people of Paraguay (Ahmed et al., 1981). 

The dosage may be gradually titrated upward at 6- to 12-month intervals as needed to achieve appropriate bone age advancement and eventual epiphyseal closure. Chronic dosing with 0.625 mg is sufficient to induce artificial cyclic menses with sequential progestin treatment and to maintain bone mineral density after skeletal maturity is achieved. 

Susceptibihty factors have been investigated in a large retrospective study of 274 patients aged under 45 years, of whom 70 had received cyclophosphamide, 84 azathiopr-ine but not cyclophosphamide, and 88 either no drug or hydroxychloroquine alone (35). The overall incidence of ovarian failure, defined as sustained amenorrhea for at least 12 months and documented by reduced estradiol concentrations, was 26, 1, and 0% respectively. The mean delay to onset of the first missed menses was 4.4 months. A higher age at the start of treatment and cumulative dose were independent risk factors for cyclophosphamide-induced ovarian failure. The incidences were 14, 28, and 50% in patients aged under 30 years, 30-39 years, and over 40 years respectively, and 4, 26, 31, 70%... 

The dried herbs of some Artemisia species have been used for the treatment of inflammation, blood diseases caused by the disturbance of menses, haematemesis, haematuria, hemorrhoids and diarrhea in Chinese, Korean and Japanese traditional medicine. In Japan, A. princeps and A. montana are the main species used for these purposes. Chlorogenic acid, methyl chlorogenate, 3,5-di-(9-caffeoylquinic acid, 4,5-di-CJ-cafifeoylquinic acid and 3,4-di-O-caffeoylquinic acid were isolated from the leaf of A. montana, and these compounds can be called "caffeetaimins" "Fig. (31)". We found that these caffeetannins inhibited the ADP plus NADPH-induced lipid peroxidation in rat liver microsomes. [17] Furthermore, as shown in "Table (12) and Table (13)", the acetone extracts of A. montana reduced the elevations of LPO, GOT and (JOT in the serum of rats fed peroxidized oil for 7 days. Caffeic acid and chlorogenic acid also inhibited the elevation of serum TG, LPO, TC, GOT and GPT "Table (14) and Table (15)". 

The patient was basically amenorrheic, having only 1 or 2 menses a year. She also experienced mild constipation, frequent gas and bloating, acne, and increasing facial hair. Oral contraceptives had been used in the past and were effective in inducing regular menstrual cycles, but amenorrhea returned as soon as they were discontinued. Birth control pills also made the acne and digestive complaints worse and obviously were not an option for promoting fertility. 

Zoapatanol. 9-[3-Hydroxy-6-i2-hydroxyethylid-ene )-2-me i h yt-2-oxepa nylJ-2,6-dim elhyl-2-n on en-S-on e. CaHMOt mol wt 338.49. C 70.97%, H 10.12%, O 18.91%. Oxepane diterpenoid isolated from the leaves of the zoapatle plant, Monlanoa tomentosa, Compositeae, which has been used by Mexican women to prepare "tea to induce menses and labor. Isoln and structure M. P. Wachter, R. M. 

Emmenagogue Substance that induces the onset of menses. 

Uterine tonics have been used historically with the belief that they improve the strength and tone of the uterine muscle, while uterine stimulants were thought to bring on menses or induce labor. Although both of these are important categories in modern herbal therapeutics, there is little... 

Fertility Anthracycline chemotherapy can cause chemotherapy-induced amenorrhoea (CIA) which is associated with infertility and symptoms of menopause. Of 165 epirubicin-treated patients recruited for a study, CIA occurred in 72 patients (43.64%). CIA was defined as the cessation of menses for at least one year after chemotherapy completion... 

---